TARS1
Basic information
Region (hg38): 5:33440696-33468091
Previous symbols: [ "TARS" ]
Links
Phenotypes
GenCC
Source:
- trichothiodystrophy (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Trichothiodystrophy 7, nonphotosensitive | AR | Allergy/Immunology/Infectious | The condition has been described as involve recurrent respiratory infections, and awareness may allow prompt diagnosis and management of infections | Allergy/Immunology/Infectious; Dermatologic; Musculoskeletal; Neurologic | 31374204 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TARS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 48 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 5 | 2 | 7 | |||
non coding | 3 | |||||
Total | 0 | 0 | 48 | 3 | 13 |
Variants in TARS1
This is a list of pathogenic ClinVar variants found in the TARS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-33441102-G-C | not specified | Uncertain significance (Apr 23, 2024) | ||
5-33441112-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
5-33441125-G-C | not specified | Uncertain significance (Jan 09, 2024) | ||
5-33445328-G-A | Trichothiodystrophy 7, nonphotosensitive • TARS1-related disorder | Benign/Likely benign (May 17, 2022) | ||
5-33445389-T-G | not specified | Uncertain significance (Mar 11, 2022) | ||
5-33448548-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
5-33448565-T-C | not specified | Uncertain significance (Jan 31, 2024) | ||
5-33448599-C-T | TARS1-related disorder | Likely benign (May 22, 2023) | ||
5-33448616-C-G | not specified | Uncertain significance (Jun 24, 2022) | ||
5-33448633-A-C | TARS1-related disorder | Benign (Feb 08, 2018) | ||
5-33448686-C-A | TARS1-related disorder | Benign (Jun 01, 2023) | ||
5-33448701-C-T | not specified | Uncertain significance (Apr 25, 2022) | ||
5-33452335-C-T | TARS1-related disorder | Benign (Nov 06, 2019) | ||
5-33453263-CT-C | TARS1-related disorder | Likely benign (Oct 29, 2019) | ||
5-33453263-CTT-C | TARS1-related disorder | Likely benign (Feb 20, 2020) | ||
5-33453263-CTTT-C | TARS1-related disorder | Likely benign (Nov 12, 2019) | ||
5-33453263-CTTTT-C | TARS1-related disorder | Likely benign (Nov 25, 2019) | ||
5-33453263-C-CT | TARS1-related disorder | Likely benign (Nov 25, 2019) | ||
5-33453311-G-A | TARS1-related disorder | Benign (Jan 30, 2018) | ||
5-33453351-G-A | not specified | Uncertain significance (Jul 27, 2022) | ||
5-33453366-A-G | not specified | Uncertain significance (Mar 20, 2024) | ||
5-33455016-C-T | TARS1-related disorder | Benign (Feb 08, 2018) | ||
5-33455042-A-G | not specified | Uncertain significance (Jun 02, 2024) | ||
5-33455050-A-G | not specified | Uncertain significance (Mar 30, 2024) | ||
5-33455059-G-A | not specified | Uncertain significance (Jan 18, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TARS1 | protein_coding | protein_coding | ENST00000455217 | 20 | 28843 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.95e-13 | 0.994 | 125678 | 0 | 70 | 125748 | 0.000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.15 | 354 | 420 | 0.842 | 0.0000224 | 5006 |
Missense in Polyphen | 118 | 159.62 | 0.73927 | 1855 | ||
Synonymous | -0.316 | 148 | 143 | 1.03 | 0.00000756 | 1360 |
Loss of Function | 2.67 | 27 | 46.7 | 0.578 | 0.00000251 | 540 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000964 | 0.000932 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000764 | 0.000761 |
Finnish | 0.0000928 | 0.0000924 |
European (Non-Finnish) | 0.000223 | 0.000220 |
Middle Eastern | 0.000764 | 0.000761 |
South Asian | 0.000171 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human);tRNA Aminoacylation;Translation;Metabolism of proteins;Glycine Serine metabolism;tRNA charging;Cytosolic tRNA aminoacylation
(Consensus)
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- loftool
- 0.546
- rvis_EVS
- 0.6
- rvis_percentile_EVS
- 82.87
Haploinsufficiency Scores
- pHI
- 0.838
- hipred
- Y
- hipred_score
- 0.648
- ghis
- 0.589
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.957
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tars
- Phenotype
Gene ontology
- Biological process
- translation;tRNA aminoacylation for protein translation;threonyl-tRNA aminoacylation
- Cellular component
- cytoplasm;cytosol;actin cytoskeleton;extracellular exosome
- Molecular function
- tRNA binding;threonine-tRNA ligase activity;protein binding;ATP binding;protein homodimerization activity